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Introduction
. In this sense, tissue 16 engineering (TE) (Fisher and Mauck, 2013; Langer and Vacanti, 17 1993) has played a key role as it has introduced new strategies 18 based on the development of composite systems that integrate 19 cells, growth factors, and scaffolds, (Drosse et al., 2008; Eisenbarth, 20 2007; Vallet-Regí and Ruiz-Hernández, 2011) avoiding major 21 drawbacks associated to autografts and allografts (O'Brien, 2011) . 22 TE develops substrates that restore, maintain or improve the 23 function of damaged tissues (Langer, 2000) . In case of damaged 24 bone, TE scaffolds with added drug delivery function, have 25 emerged as an attractive approach in recent years (Catauro 26 et al., 2015a; Mouriño et al., 2013) .
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In bone TE, biocompatible, biodegradable and interconnected 28 highly porous scaffolds in a three dimensional (3D) geometry are 29 desirable. In this sense, composite scaffolds which combine 30 biopolymers and bioactive ceramics are being developed for this 31 application (Catauro et al., 2015b; Garg and Goyal, 2014; Mallick 32 and Cox, 2013; Mouriño et al., 2013) . Great attention has been 33 focused Q4 on hydrogels as biopolymers because of its resemblance to 34 the extracellular fluids (Fisher et al., 2014; Malda et al., 2013) . They 35 have been studied for different medical applications, such as drug 36 delivery systems and bionanotechnology (Ankareddi and Brazel, 37 2007; Gaharwar et al., 2014; Peppas et al., 2006) . In particular, the 38 natural polysaccharide agarose, which is a thermo sensitive 39 hydrogel, has been successfully used in tissue engineering and 40 other biological applications (Cheng et al., 2007; Gruber et al., 41 2006; Luo and Shoichet, 2004; Marras-Marquez et al., 2014; Rotter 42 et al., 1998) . Inclusion of hydroxyapatite (the mineral phase 43 present in bone) on hydrogels improves both the mechanical 44 stability and bioactivity (Juhasz et al., 2010) and also induces an 45 osteoinductive and osteoconductive behaviour. In this sense, 46 carbonate-substituted hydroxyapatite shows better bioactivity 47 in vitro and in vivo than stoichiometric hydroxyapatite 48 (Porter et al., 2005 Lee et al., 2008) .
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Most of the fabrication processes to obtain scaffolds with 3D 60 designed porosity employ organic solvents, high temperature or 61 acidic conditions that preclude the incorporation of bioactive 62 molecules and drugs (Fierz et al., 2008; Martínez-Vázquez et al., 63 2013). In previous work we have described an easy and inexpensive 64 method to obtain agarose/hydroxyapatite scaffolds with hierar-65 chical porosity at room temperature for bone repair application 66 Román et al., 2011) . Biocompatibility studies 67 demonstrate that these scaffolds allow the culture of osteoblasts 68 inside and outside the material (Alcaide et al., 2010; Cabañas et al., 69 2014 (Cattalini et al., 2012; 83 Coleman et al., 2011; Giger et al., 2013; Nancollas et al., 2006;  84 Rosenqvist et al., 2014) . On the other hand, ibuprofen is commonly 85 prescribed to relieve pain due to inflammation that arises from 86 different osseous pathologies or surgical treatments (Mouriño and 87 Boccaccini, 2010; Rainsford, 2013) , and it is also commonly 88 prescribed simultaneously with bisphosphonates in order to 89 minimize one of its main side effects: the "flu-like syndrome" 90 (Coleman et al., 2011 Román et al., 2011; The method used to obtain these DDDS allows a complete has been observed in other basic materials (Krupa et al., 2010 (Vorndran et al., 2010) . 
361 362 where M t /M is the accumulative amounts of drug release at time t; 363 k is a kinetic constant and n is an exponent which characterised the 364 mechanism of drug release and it ranges between n = 0.5 diffusion mechanism with some physico-chemical interference 370 (Chen and Zhu 2012; Tamimi et al., 2008) . These data agree with 371 the nHCA and ZOL interaction described above, the formation of a The slower ibuprofen release from chitosan spheres (inside a 400 scaffold or isolated) can be described using, again, the Korsmeyer- 401 Peppas equation (Table 1) . In both cases, the n value is close to 0. The apatite/agarose scaffold itself could allow bone regeneration, 413 since previous in vitro studies (Cabañas et al., 2014) 
